Niagen Bioscience, Inc. (NAGE) Operating cash flow 2016–2025
Niagen Bioscience, Inc. (NAGE) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$13.5MFY2025 · since FY2016: -$2.9M → $13.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $13.5M | +11.5% |
| FY2024 | $12.1M | +70.1% |
| FY2023 | $7.1M | +147.1% |
| FY2022 | -$15.1M | +37.5% |
| FY2021 | -$24.2M | -128.0% |
| FY2020 | -$10.6M | +48.1% |
| FY2019 | -$20.4M | +2.2% |
| FY2018 | -$20.9M | -113.3% |
| FY2017 | -$9.8M | -233.9% |
| FY2016 | -$2.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice